The present invention provides isolated peptides having the amino acid sequence of SEQ ID NO: 34 or fragments thereof, which bind to HLA antigen and induce cytotoxic T lymphocyte (CTL). The present invention further provides peptides which include one, two, or several amino acid insertions, substitution or addition to the aforementioned peptides or fragments, but still have the cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical substances or compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical substances or compositions of the present invention may be used for treating cancer or tumor.本發明提供具有序列辨識號:34之胺基酸序列的經分離胜肽,或其片段,其與HLA抗原結合並誘導細胞毒殺性T淋巴球。本發明更提供包括一、二或數個胺基酸插入、取代或加入至上述胜肽或其片段,但仍具有細胞毒殺性T淋巴球誘發能力的胜肽。此外,所提供者為編碼出任何這些上述胜肽之的核酸與包括任何上述胜肽或核酸之藥學物質或組合物。這些本發明之胜肽、核酸、藥學物質或組合物可被用來治療癌症或腫瘤。
